6. Absence of extra-pulmonary disease, except liver metastases suitable to curative treatment.
You may not be if
1. Patient has previously received more than 1000 mg of oxaliplatin
2. Left Ventricular Ejection Fraction \<50%
3. History of significant pulmonary disease or pneumonitis
4. Pregnant or lactating females
5. Age 71 or older, or less than 18 years
6. Inability to understand the informed consent process
7. Hypersenstivity to oxaliplatin
8. Patients with Heparin-induced thrombocytopenia (HIT)
9. Patients who cannot receive cefazolin or methylprednisolone due to allergy or another reason can be included but will not receive the drug they cannot tolerate
10. Current participation in another therapeutic clinical trial
Clareo Health | In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
